Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Habermeier, Alice; Werner, Anke; Munder, Markus et al.
Arginine transport in human primary granulocytesAMINO ACIDS. Bd. 47. H. 8. 2015 S. 1617-1617
Guerard, M.; Baum, M.; Bitsch, A. et al.
Assessment of mechanisms driving non-linear dose-response relationships in genotoxicity testingMUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH. Bd. 763. 2015 S. 181-201
Paschka, Peter; Schlenk, Richard F.; Gaidzik, Verena I. et al.
ASXL1 mutations in younger adult patients with acute myeloid leukemia: a study by the German-Austrian Acute Myeloid Leukemia Study GroupHAEMATOLOGICA. Bd. 100. H. 3. 2015 S. 324-330
O'Connor, Owen A.; Horwitz, Steven; Masszi, Tamas et al.
Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) StudyJOURNAL OF CLINICAL ONCOLOGY. Bd. 33. H. 23. 2015 S. 2492-U21
Zahnreich, Sebastian; Ebersberger, Anne; Kaina, Bernd et al.
Biodosimetry Based on gamma-H2AX Quantification and Cytogenetics after Partial- and Total-Body Irradiation during Fractionated RadiotherapyRADIATION RESEARCH. Bd. 183. H. 4. 2015 S. 432-446
Sicking, I; Schmidt, M
Biologisch stratifizierte Therapie - metastasiertes Mammakarzinomgynäkologie + geburtshilfe. Bd. 20. H. 2. 2015 S. 37-42
Schmidt, M; Maass, N
Biomarker und Risikoabschätzung beim Mammakarzinom - Genexpressionssignaturen auf dem Weg in die RoutineDer Gynäkologe. Bd. 48. 2015 S. 65–70
Hagelauer, Nadine; Ziebart, Thomas; Pabst, AndreasM. et al.
Bisphosphonates inhibit cell functions of HUVECs, fibroblasts and osteogenic cells via inhibition of protein geranylgeranylationCLINICAL ORAL INVESTIGATIONS. Bd. 19. H. 5. 2015 S. 1079-1091
Brenner, W.; Haber, T.; Junker, K. et al.
Bone metastasis by renal cell carcinoma. Importance of calcium and calcium-sensing receptorUROLOGE. Bd. 54. H. 6. 2015 S. 839-843
Haber, Tobias; Joeckel, Elke; Roos, Frederik C. et al.
Bone Metastasis in Renal Cell Carcinoma is Preprogrammed in the Primary Tumor and Caused by AKT and Integrin alpha 5 SignalingJOURNAL OF UROLOGY. Bd. 194. H. 2. 2015 S. 539-546